Third Age Health Releases FY23 Preliminary Results

1

FY23 Results Update: Third Age Health Services
Dear Shareholders,

We are pleased to report that we have made significant progress in executing our growth strategy
and delivering on our commitment to providing exceptional primary medical services to the Aged
Residential Care (ARC) sector and in our General Practices.

Performance Improvement
During the first half of the year, we completed implementation of resource and infrastructure that
was previously lacking but crucial for stability in our existing business and establishing a sustainable
operating model for profitable growth.

Addressing client churn and early departures of clinicians presented a significant challenge. However,
we have successfully reversed this trend. Over the past year, we have not only achieved net growth
in ARC clients and clinicians but also seen a marked improvement in client engagement.
Despite the challenges faced during the first half of the year, the business has demonstrated
remarkable resilience and adaptability, and we are encouraged by the improved performance in the
second half, which saw our results outpace those of the first half. This is a testament to the
dedication of our team and our focus on operational efficiency, continuous improvement, and
creating value for our customers.

Our improved performance in the latter half of the year was driven by a combination of factors,
including the ongoing integration of the acquired general practice clinics, resource re-balancing
which will reduce cost by $150k per annum as signalled in the first half announcement, and the
recruitment of additional clinical practitioners to meet the growing demand for our services.
We have been able to increase our organic revenue growth rate and improve our gross profit margins
demonstrating the strength of our core business and our commitment to delivering high-quality
primary care services. Furthermore, our focus on operational efficiency and continuous improvement
is yielding promising results, enabling us to expand our services and reach new customers while
increasing profitability.

Our focus on clinical quality and customer value has resulted in a consistently improving Net
Promoter Score, securing 4 additional ARC facilities as customers, and significantly reducing
regrettable exits of facilities by 6 (FY23 3 regrettable exits, FY22 9).

Clinical Workforce
We have improved the acquisition and retention of clinicians by taking steps to make it easier for
them to work for us. We ended the year with 68 clinicians up 30 (79%) from the prior year with an
increase in the number of clinicians who now work for us across both ARC and GP settings. The
ability to work in both settings is both more appealing for clinicians and builds a level of resiliency in
our business.

While we are making progress in growing our team of clinicians, we cannot ignore the big picture.
The primary care sector has some tough challenges ahead. There is no simple solution here. New
Zealand needs to train more doctors, right here in our own medical schools. New Zealand needs to
make it easier for nurses and doctors from overseas to come work with us, and need to make sure
our nurses in primary care get paid fairly.

2


Kaizen / Continuous Improvement
During the second half of the fiscal year, we commenced the roll out of Kaizen (aka Lean) which is a
management philosophy that seeks to eliminate waste and create a culture of continuous
improvement. It has been successful in a range of industries, and we believe it can help your
company become more competitive and profitable.

Kaizen is based on the simple principle that waste is anything that does not add value to the
customer. It is a comprehensive strategy that emphasises not just cost reduction, but also
enhancements in quality, productivity, and efficiency. Our aim is for Kaizen to become an integral
part of our operational DNA.

To date most processes in our ARC business have been manual with significant waste across the
value stream. Following a thorough review, we recently commenced digitising a range of these
processes. Digitisation will reduce waste and make these processes easier, better, and faster for our
customers and our team. We expect to roll this digital platform out to a few pilot customers from
early 2024.

Capital Allocation
Our approach to capital allocation is guided by the $1 rule, a principle first articulated by Warren
Buffett in his 1983 letter to shareholders. We will retain earnings only when we see a reasonable
prospect of creating at least one dollar of market value for every dollar retained, assessed over a
rolling 5-year period. This approach ensures that we continually strive to generate high returns on
any capital we retain.

Currently, we distribute 75% of our earnings as dividends, paid semi-annually. To accelerate returns
to shareholders, we have decided to shift from semi-annual to quarterly dividend payments going
forward.

During the past year, the idea of initiating a share buyback was considered. However, as two
shareholders each hold more than 20% of the issued shares, we found ourselves limited by the
provisions of the Takeover's Code. Looking ahead, we may contemplate seeking the consent of
shareholders to commence a share buyback.

We are mindful of maintaining a strong balance sheet and the financial flexibility that comes with it.
To that end, we plan to deleverage with a target Debt-to-EBITDA ratio of 1x.

A Unique Business
We believe you own a uniquely high-quality business, and we would like to explain why. First, we
have a business model that brings in recurring and predictable revenue streams. This provides a
stable financial bedrock.

Secondly, we operate in a sector with long-term growth prospects due to an ageing population. This
demographic shift translates into a growing demand for our services in the years to come. It is a
trend we are well-positioned to benefit from, and one that provides us with a clear and visible path
for growth.

3

Thirdly, we play a small but crucial role in a larger value stream. ARC facilities cannot operate without
the services we provide. Our indispensability to these facilities underscores the critical nature of our
work and reinforces our importance in the healthcare ecosystem.

Fourthly, we have been able to generate significant free cash flow with high returns on tangible
capital. That allows us to invest in growing the business and widening our moat while consistently
returning capital to shareholders.

Finally, there remains potential for opportunistic consolidation of other providers of medical services
to ARC. We can take advantage of these opportunities as they arise, which should only strengthen
our position in the market.

Alignment of Interests
As an owner-oriented company, we seek to cultivate an alignment of interests with shareholders. To
this end we encourage share ownership among our directors and management. Over the year Board
members and management acquired a further 96,946 shares bringing their collective ownership to
45% of the company's issued shares. That is not just a vote of confidence - it is us putting our money
where our mouth is.

Management’s incentive scheme has also been revamped. The Short-Term Incentive is now tied to
the achievement of organic revenue and profit growth. Similarly, the Long-Term Incentive options are
vested based on the realisation of Total Shareholder Return targets. This ensures that our
management's success is linked to the company's performance, further aligning management with
shareholders.

Outlook
Looking ahead to FY24, we are poised for an exciting period of profitable organic growth. Our
investments thus far have been carefully calibrated to fuel future growth, and we are focussed on
reaping the benefits of these decisions with increased returns on capital.

Turning to our financial outlook, we expect both our organic revenue and underlying profit in FY24 to
outpace those of FY23. We expect performance in the first half of FY24 will not only surpass the
results of the second half of FY23 but also set a promising tempo for the remainder of the fiscal year.
Our long-term goal remains to maximise returns on capital and the average annual rate of increase in
intrinsic value per share.

In conclusion we want to express our heartfelt gratitude to our committed team and to you, our
shareholders, for your continued support.

Sincerely,


John Fernandes Tony Wai
Chairman CEO

---

Third Age Health Services Limited
Consolidated statement of comprehensive income
For the year ended 31 March 2023



2023 2022

Notes $000 $000
Revenue

11,467 5,900
Cost of services

(5,174) (2,205)
Gross profit

6,293 3,695

Other income

35 31

Employees and contractors

(2,814) (1,251)
Professional and consulting fees

(503) (486)
Other expenses

(1,221) (262)
Operational expenses

(4,538) (1,999)

Loan impairment

(233) -

EBITDA

1,557 1,726

Depreciation

(304) (79)
Amortisation of intangibles

(240) (63)
Finance costs

(286) (23)

Profit before income tax

727 1,561

Income tax expense

(316) (388)

Profit for the period

411 1,173

Other comprehensive income

- -

Total comprehensive income for the period

411 1,173

Profit and total comprehensive income attributable to:

Shareholders of the parent

438 -
Non-controlling interests

(27) -

Profit for the year

411 1,173

Earnings per share

Basic earnings per share (cents)

4.11 11.93
Diluted earnings per share (cents)

4.13 11.84







These Consolidated Financial Statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited
Consolidated statement of change in equity
For the year ended 31 March 2023




Share
Capital
Share
Based
Payments
Reserve
Retained
earnings
Non-
controlling
Interest Total

Notes $000 $000 $000 $000 $000
Balance at 1 April 2021

173 607 1,196 - 1,976

Profit for the year

- - 1,173 - 1,173
Total comprehensive income for the year

- - 1,173 - 1,173

Shares issued

342 - - - 342
Dividend

- - (831) - (831)
Tax credit on share based payments

- 21 - - 21
Deferred tax credit on share based payments

- 9 - - 9
Share based payments

- 6 - - 6
Balance at 31 March 2022

515 643 1,538 - 2,696

Balance at 1 April 2022

515 643 1,538 - 2,696

Profit for the year

- - 438 (27) 411
Total comprehensive income for the year

- - 438 (27) 411

Shares issued 81 - - - 81
Dividend - - (647) - (647)
Tax credit on share based payments - 4 - - 4
Deferred tax credit on share based payments - (9) - - (9)
Share based payments - 8 - - 8
Balance at 31 March 2023

596 646 1,329 (27) 2,544



















These Consolidated Financial Statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited
Consolidated statement of financial position
For the year ended 31 March 2023



2023 2022
Notes $000 $000
Current assets

Cash and cash equivalents

1,355 1,124
Trade and other receivables
1,117 386
Loan receivable
80 313
Total current assets
2,552 1,823



Non-current assets


Property, plant and equipment
154 22
Right-of-use-assets
2,967 1,093
Intangible assets
4,351 1,902
Trade and other receivables
20 20
Deferred tax asset
- -
Total non-current assets
7,492 3,037



Total assets
10,044 4,860



Current liabilities


Trade and other payables
1,395 668
Current tax liabilities
94 55
Employee share purchase plan deposits
- 75
Bank Loan - current
281 -
Lease liabilities
283 111
Total current liabilities
2,053 909



Non current liabilities


Trade and other payables 2 29
Lease liabilities 2,755 977
Deferred tax liability 630 249
Bank Loan 2,060 -
Total non current liabilities
5,447 1,255



Total liabilities 7,500 2,164



Net assets
2,544 2,696
Equity


Share capital
596 515
Share based payment reserve

646 643
Retained earnings

1,302 1,538
Equity attributable to the Group

2,544 2,696


Shareholders of the parent

2,571 -
Non-Controlling Interests

(27) -

Total Equity

2,544 2,696

Net tangible assets/(liability) (cents per share) (11.7) 10.5

These Consolidated Financial Statements are to be read in conjunction with the accompanying notes

Third Age Health Services Limited
Consolidated statement of cash flows
For the year ended 31 March 2023



2023 2022

Notes $000 $000
Cash flows from operating activities

Receipts from operating activities

10,860 5,885
Payments to suppliers and employees

(9,289) (4,147)
Interest received

7
16
Interest paid

(107) (23)
Income taxes paid

(390) (691)
Net cash flows from operating activities
1,081 1,040



Cash flows from investing activities

Payments purchase for property, plant and equipment
(52) (3)
Acquisition of general practices
(2,300) (967)
Net cash flows used in investing activities
(2,353) (970)



Cash flows from financing activities

Deposits received under share purchase plan 1
72
Share purchase plan deposits applied to acquire shares (76)
(342)
Proceeds from issuing shares 72
342
Principal elements of loan repayments (37)
47
Payment of lease liabilities (198)
(63)
Dividend paid

(638)
(831)
Bank Loan

2,378
-
Net cash flows from financing activities
1,502 (775)



Net increase in cash and cash equivalents

231 (705)


Cash and cash equivalents at the beginning of the period

1,124 1,829
Cash and cash equivalents at the end of the period

1,355 1,124















These Consolidated Financial Statements are to be read in conjunction with the accompanying notes.

Third Age Health Services Limited
Corporate directory

1. Reporting entity

These preliminary full year report announcement of Third Age Health Services Limited and its subsidiaries (the
"Group") for the full year ended 31 March 2023 was authorised for issue in accordance with a resolution of the
Directors. The Parent is incorporated and domiciled in New Zealand and registered under the Companies Act
1993. The parent's shares are publicly traded on the New Zealand Stock Exchange (NZX) and are listed on the
main board of the NZX. The principal trading activity of the Group is the provision of medical services to the
aged care sector. Those companies included in the Group are disclosed in note 19.

2. Statement of accounting policies

Accounting policies remain consistent with the prior year ended 31 March 2022 financial statements.

3. Net tangible assets

The Group has net tangible liabilities as at 31 March 2023 of (11.7) cents per share (2022: net tangible assets
10.5). The movement in NTA is the result of changes in the Statement of Financial Position composition,
substantially increased Intangibles and Bank Debt.
4. Segment information

4.1. Products and services from which reportable segments derive their revenue

The Group's reportable segments are as follows:
 Aged medical residential care services, being the provision of medical care services to the aged care
sector.
 General practice medical services

4.2. Segment revenues and results

The following is an analysis of the Group’s revenue and results from operations by reportable segment:

Segment revenue 2023 2022

$000 $000
Aged medical care services 5,948 4,712
General practice medical services 5,519 1,188
Total for continuing operations 11,467 5,900


Segment profit before tax 2023 2022

$000 $000
Aged medical care services 567 1,340
General practice medical services 160 221
Total for continuing operations 727 1,561

Third Age Health Services Limited
Corporate directory


Segment profit includes the following items:

Segment profit includes the following items:

For the year ended 31 March 2023 Aged care General practice

medical services medical services

$000 $000
EBITDA 713 844
Depreciation (4) (300)
Amortisation of intangibles - (240)
Interest expense on leases - (99)
Interest on ANZ Loan - (144)
Interest on Loss on modification of borrowings - (43)
Profit before tax 709 18

Add back: Loan impairment 233 -
Profit before tax from underlying core operations 942 18

Income tax expense (270) (46)
Profit for the period 439 (28)


For the year ended 31 March 2022 Aged care General practice

medical services medical services

$000 $000
EBITDA 1,321 385
Depreciation (1) (78)
Amortisation of intangibles - (63)
Interest expense on leases - (23)
Interest income 20 -
Profit before tax 1,340 221
Income tax expense (326) (62)
Profit for the period 1,014 159


EBITDA represents profit before tax excluding amounts for depreciation and amortisation expenses, interest
expenses and interest income.


4.3. Segment assets and liabilities

Segment assets 2023 2022

$000 $000
Aged medical care services incl support functions 2,446 1,513
General practice medical services 8,784 4,014
Total segment assets 11,230 5,527

Intercompany elimination (1,185) (667)
Total segment assets 10,045 4,860

Third Age Health Services Limited
Corporate directory


Segment liabilities
2023
2022

$000 $000
Aged medical care services incl support functions 1,048 922
General practice medical services
7,637 1,909
Total segment liabilities
8,685 2,831



Intercompany elimination (1,185) (667)
Total segment liabilities
7,500
2,164

5. Costs of employees, contractors, and directors includes:



2023
2022

Note
$000 $000
Salaries and wages

2,334 916
Short term incentives

40 20
Defined contribution (KiwiSaver)

132 20
Share based payments expense
24.3
8 13
Employee benefit expense

2,514 969



Contractors

300 305
Former CEO Incentives

- (23)


2,814 1,274

Costs of employees has increased during the year due to the addition of three new practices adding $972k
salaries and wages and $38k Kiwisaver combined with investment in new support office positions to enhance
infrastructure growth.

6. Finance costs


2023
2022

$000 $000
Interest expense on leases 144 23
Interest on ANZ Loan 99 -
Interest on Loss on modification of borrowings 43 -

286 23

Third Age Health Services Limited
Corporate directory

7. Share Capital

Ordinary shares
All ordinary shares rank equally with one vote attached to each fully paid share. Total issued share capital is
10,004,149 ordinary shares (2022: 10,000,000). At 1 April 2021 there were 250,000 shares held for specific
participants of the Third Age Employee Share Purchase Plan Trust (“Trust”). During the year ended 31 March
2022, 200,000 shares were issued and the remaining 50,000 shares were issued during the year ended 31
March 2023. As at 31 March 2023, of the total number of issued shares, nil (2022: 50,000) were held in trust
for specific participants under the Employee Share Purchase Plan (ESPP, note 24.1).



Treasury shares

Authorised

Issued and shares held Total issued and fully

Share Capital in Trust

paid shares

Note $0 $0 $0 000's
Balance at 1 April 2022

592 (76) 516 10,000
Shares issued 24.1 9 76 84 4
Share issue transaction costs

(4) - (4) -
Balance at 31 March 2023

596 (0) 596 10,004

Balance at 1 April 2021

592 (418) 173 10,000
Shares issued

- 342 342 -
Balance at 31 March 2022

592 (76) 515 10,000


8. Earnings per share

Basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Group by
the weighted average number of ordinary shares outstanding during the financial year, excluding treasury
shares.

Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take
into account the after-income tax effect of interest and other financing costs associated with dilutive potential
ordinary shares, and the weighted average number of ordinary shares that would have been outstanding
assuming the conversion of all dilutive potential ordinary shares.

Reconciliation of earnings used in calculating earnings per share

2023
2022

$000 $000
Net profit attributable to the ordinary shareholders of the
Group
436 1,173
Earnings used in the calculation of basic earnings per share 436 1,173

Weighted average number of shares used as the denominator

2023
2022

Shares Shares

Third Age Health Services Limited
Corporate directory

000's 000's
Weighted average number of ordinary shares used as the
denominator in calculating basic earnings per share
9,993 9,832

Adjustments for calculation of diluted earnings per share:

Employee share options (29) 74

Weighted average number of ordinary shares and potential
ordinary shares used as the denominator in calculating diluted
earnings per share
9,964 9,906

9. Dividends

Dividends declared and paid during the year ended 31 March
2023:
Cents per share $000
Interim dividend 2.45 244
Final dividend for the year ended 31 March 2022 4.05 403


647

Dividends declared and paid during the year ended 31 March
2022:
Cents per share $000
Interim dividend 4.52 450
Final dividend for the year ended 31 March 2021 3.91 381


831


10. Loan receivable


2023
2022

$000 $000
Current 80 313

80 313


Following the failure of TADH to maintain monthly repayments of the loan, the Company sought to have TADH
placed in liquidation during the period, and liquidators were appointed.
While the loan to TADH is unsecured, the Board of TADH provided a written warranty that it had received
legally binding assurances of financial support from its major shareholders such that in the borrower’s opinion
(acting reasonably and in good faith) TADH would make all repayments.
Michael Haskell is the Director of TADH, and its major shareholders are Michael Haskell & Associates Limited
and Bevan Walsh, both also major shareholders of the Company.
The liquidators have made an interim distribution of $80,000 to the Company after balance date. As it has
been over a year since this issue first arose and since the liquidators have not yet recovered the full amount
and may need to engage in a court process to do so, given the uncertainty around that process the Company
has conservatively taken a provision of $233k for the remaining balance of the loan.

---

Third Age Health delivers 2H underlying NPATA
1
of $363k up 12% on
1H, and FY23 underlying NPATA
1
of $687k down 41% on FY22
FY23 NPAT $411k down 65.0% on FY22 $1,173k

FY23 Business Highlights
Third Age Health (TAH) is New Zealand’s leading provider of quality health care services for older
people; supporting those living in care homes, hospital level care, secure dementia units, retirement
villages and in their own homes. TAH currently provide services to over 60 Aged Residential Care
(ARC) facilities throughout the country, including some of the largest aged care providers in New
Zealand. In addition, Third Age Health has a family of general practices providing quality primary
healthcare for local communities.

• Growth: TAH has significantly expanded its national footprint and market share in FY23.
o increased the number ARC patients we provide care to by 20%, with 11.5% of ARC
population across NZ currently supported by TAH.
o doubled the number of general practices within our network to 6, and
o Grew our combined enrolled patient population across both ARC and general
practice by 107%.
o Our core Aged Care Services grew by 26% over the prior year Aged Care revenue,
while organic growth of our General Practice grew by 53% over prior year General
Practice revenue.
• Clinical Team and People: We ended the year with 68 clinicians up 30 (79% increase) from
the prior year with an increase in the number of clinicians who now work for us across both
ARC and GP settings, making up 71% of the overall team.

FY23 Financial Highlights
• Group revenue up 94% to $11,467k (FY22: $5,900k)
• 2H revenue up 51% to $6,889k (1H: $4,578)
• Full year organic revenue growth of +$1,871k (FY22: +$132k)
• Recent acquisitions adding $3,696k to revenue for FY23 (FY22: $278k)
• 2H acquisition revenue $2,251k (1H: $1,445k)
• Underlying NPATA
1
down 41% at $687k (FY22: $1,173k)
• 2H underlying NPATA
1
up 12% at $363k (1H: $324k)
• Underlying NPBTA
1
down 26% at $1,243k (FY22: $1,625k)
• 2H underlying NPBTA
1
up 26% at $694k (1H: $549k)
• Net cashflow year on year increase of $936k; increased cashflow of $231k for FY23 and a
decrease of $705k in cashflow in FY22.



1
Underlying NPATA and NPBTA is adjusted for (i) non-cash amortisation charges arising as a result of purchase accounting
rules (ii) non-recurring provision related to the TADH loan

Financial Highlights $'000
TAHS and Controlled Entities
1H 2H % FY23 FY22 %`
Revenue 4,578 6,889 50.5% 11,467 5,900 94.4%
Underlying EBIT 597 656 9.9% 1,253 1,647 -23.9%
EBIT Margin 13% 10% -3.5% 11% 28% -17.0%
Underlying NPBTA 549 694 26.4% 1,243 1,625 -23.5%
NPBTA
1
%
12% 10% -1.9% 11% 28% -16.7%
Underlying NPATA
1

324 363 12.0% 687 1,173 -41.4%
NPATA
1
%
7% 5% -1.8% 6% 20% -13.9%



Statutory NPAT
324 87 -73.1% 411 1,173 -65.0%
Basic earnings per share
3.24 0.87 -73.1% 4.11 11.93 -65.5%
Ordinary dividends per share (cents)
2.45 2.58 5.3% 5.03 8.57 -41.3%
Return on Equity
12% 3% -8.8% 16% 50% -68.8%
Return on Capital Employed
10% 14% 4.4% 12% 32% -20.0%


Acquisition Activity

Acquired Revenue
2

1,445 2,251 55.7% 3,696 278 1229%

Financial Performance
• Revenue of $ 11.467m (+$5.9m up 94%): Revenue growth during the year from two new
clinics of $2,589k when combined with revenue from a third clinic acquired at the end of
March 2022 contributed 66% of total revenue growth. Revenue from organic growth
contributed 33% of the overall growth.
• Underlying NPATA
1
of $676k down 43% from FY22: underlying NPATA is adjusted for non-
cash amortisation charges arising from purchase accounting rules and a non-recurring
provision relating to the impairment of the TADH loan.
• Cashflow: Cash and cash equivalents increased to $1,355k in FY23 (FY22: $1,124k). This
signifies an improved liquidity position, attributed to positive cash flows from operating
activities of $1,081k for FY23 (FY22: $1,040).
• Debt: acquisition activity during FY23 was funded by a new debt facility of $2,341k (FY22: nil)
• Increased investment: During the first half of the year implementation of resource and
infrastructure that was previously lacking but crucial for stability in our existing business and
establishing a platform for profitable growth was completed.



2
Note – 2 acquisitions completed in FY22, all revenue for second falls into FY23 due to the timing of acquisition
at 31 March 2022.

Current Year Acquisitions
During FY23, TAH completed two acquisitions of local general practices with estimated total annual
revenues of $4.7m. The acquisitions form part of TAH’s future growth strategy to extend services,
focused on providing a consistent primary health service as people move from community living into
the aged care setting. Both acquisitions have contributed positively to Group revenues since their
acquisition. Completed acquisitions are listed in the table below:

Acquired Location Acquired Revenue
May 22 Devonport, Auckland $770k
Oct 22 St Heliers, Auckland $1,819k


Dividends paid in FY23
During the year TAH paid an interim dividend of 2.45 cents per share in ordinary dividends. We
expect to pay a final dividend of 2.58 cents per share making the total dividend for FY23 5.03 cents
per share.
Dividend Declaration
We are pleased to announce a fully imputed dividend per share, in line with our dividend policy of
2.58 cents per share.

The board of directors of Third Age Health Services Limited has approved the release of this
document to the market.

About Third Age Health (NZX:TAH)
Third Age Health is New Zealand’s only specialised provider of general practice health care services
for older people living in retirement villages, private hospitals, secure dementia units as well as in
communities across New Zealand. A dedicated Third Age Health clinical team provides onsite clinics,
rostered rounds and after hours on-call healthcare services aimed at supporting the health and
wellbeing of older people to improve quality of life. As well as providing clinical services for over 60
aged care facilities throughout New Zealand, Third Age Health owns several general practices
providing quality primary healthcare to people of all ages.
www.thirdagehealth.co.nz

---

NZX:TAH
Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)
Updated as at 17 October 2019


Results for announcement to the market
Name of issuer Third Age Health Services LImited
Reporting Period 12 months to 31 March 2023
Previous Reporting Period 12 months to 31 March 2022
Currency
Amount (000s) Percentage change
Revenue from continuing
operations
$11,467 94%
Total Revenue $11,467 94%
Net profit/(loss) from
continuing operations
$411 -65%
Total net profit/(loss) $411 -65%
Interim/Final Dividend
Amount per Quoted Equity
Security
$ 0.02577421
Imputed amount per Quoted
Equity Security
$0.01002331
Record Date 8 June 2023
Dividend Payment Date 20 June 2023
Current period Prior comparable period
Net tangible assets per
Quoted Equity Security
$(0.117) $0.105
A brief explanation of any of
the figures above necessary
to enable the figures to be
understood
Please refer to the accompanying market announcement and
unaudited financial statements
Authority for this announcement
Name of person

authorised
to make this announcement
Denice Bennett, Chief Financial Officer
Contact person for this
announcement
Denice Bennett
Contact phone number 021 765 303
Contact email address deniceb@thirdagehealth.co.nz
Date of release through MAP

26 05 2023

Unaudited financial statements accompany this announcement.